Gene · 974
Papers4,161
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 4,161
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| [Clinical Features and Prognosis of Patients with Primary Extranodal Diffuse Large B-Cell Lymphoma]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2024 | 39743255 | PubTator, text mining | PubMed |
| Mutational Landscape of Bone Marrow CD19 and CD138 Cells in Waldenström Macroglobulinemia (WM) and IgM Monoclonal Gammopathy of Undetermined Significance (IgM MGUS). | Cancer Med | 2024 | 39711167 | PubTator, text mining | PubMed |
| Preclinical development of three novel CARs targeting CD79b for the treatment of non-Hodgkin's lymphoma and characterization of the loss of the target antigen. | J Immunother Cancer | 2024 | 39694704 | PubTator, text mining | PubMed |
| Intravascular large B-cell lymphoma arising in the pituitary gland: A case report. | Medicine (Baltimore) | 2024 | 39686426 | PubTator, text mining | PubMed |
| Heterogeneous Surface CD79b Expression in Aggressive B-Cell Lymphomas Assessed by Flow Cytometry on Lymph Node Biopsies. | Cancers (Basel) | 2024 | 39682155 | PubTator, text mining | PubMed |
| Comparative analysis of somatic mutations in MYD88, CD79B, CARD11, and BTK between gastric marginal zone B-cell lymphoma of MALT and diffuse large B-cell lymphoma. | Ann Hematol | 2024 | 39663255 | PubTator, text mining | PubMed |
| TriTan: an efficient triple nonnegative matrix factorization method for integrative analysis of single-cell multiomics data. | Brief Bioinform | 2024 | 39581871 | PubTator, text mining | PubMed |
| Primary seminal vesicle diffuse large B-cell lymphoma: a case report and review of the literatures. | Front Immunol | 2024 | 39539541 | PubTator, text mining | PubMed |
| [Analysis of Therapeutic Efficacy and Adverse Prognostic Factors of Secondary Central Nervous System Lymphoma]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2024 | 39479826 | PubTator, text mining | PubMed |
| Targeting DLBCL by mutation-specific disruption of cancer-driving oncogenes. | Front Genome Ed | 2024 | 39469218 | PubTator, text mining | PubMed |
| Clinicopathological characteristics and genomic profiling in patients with transformed lymphoma: a monocentric retrospective study. | Ann Med | 2024 | 39460552 | PubTator, text mining | PubMed |
| [Treatment of refractory diffuse large B-cell lymphoma involving the central nervous system with polatuzumab vedotin-based regimen: a case report and literature review]. | Zhonghua Xue Ye Xue Za Zhi | 2024 | 39414613 | PubTator, text mining | PubMed |
| [Efficacy and safety analysis of the OR-CHOP regimen for the treatment of MCD subtype diffuse large B cell lymphoma in the real-world setting]. | Zhonghua Xue Ye Xue Za Zhi | 2024 | 39414605 | PubTator, text mining | PubMed |
| [Clinicopathological and genetic analysis of interstitial disease-like pulmonary intravascular large B cell lymphoma]. | Zhonghua Xue Ye Xue Za Zhi | 2024 | 39414604 | PubTator, text mining | PubMed |
| scDRMAE: integrating masked autoencoder with residual attention networks to leverage omics feature dependencies for accurate cell clustering. | Bioinformatics | 2024 | 39404795 | PubTator, text mining | PubMed |
| scCTS: identifying the cell type-specific marker genes from population-level single-cell RNA-seq. | Genome Biol | 2024 | 39402623 | PubTator, text mining | PubMed |
| Systemic deficits in lipid homeostasis promote aging-associated impairments in B cell progenitor development. | bioRxiv | 2024 | 39386685 | PubTator, text mining | PubMed |
| Testicular large B-cell lymphoma is genetically similar to PCNSL and distinct from nodal DLBCL. | Hemasphere | 2024 | 39380845 | PubTator, text mining | PubMed |
| Cluster of Differentiation Markers and Human Leukocyte Antigen Expression in Chronic Lymphocytic Leukemia Patients: Correlations and Clinical Relevance. | Curr Issues Mol Biol | 2024 | 39329950 | PubTator, text mining | PubMed |
| Tuning Responses to Polatuzumab Vedotin in B-cell Lymphoma. | Cancer Discov | 2024 | 39228298 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/974/papers?page=12